Jacob Laubach, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM (NCT04653246) | Jacob Laubach, MD | 2021-07-13 |
Track Jacob Laubach, MD automatically
Every clearance here is in the API, with alerts when new ones post.